These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22380870)

  • 21. Marsdenia tenacissima extract suppresses A549 cell migration through regulation of CCR5-CCL5 axis, Rho C, and phosphorylated FAK.
    Lin SS; Li FF; Sun L; Fan W; Gu M; Zhang LY; Qin S; Yuan ST
    Chin J Nat Med; 2016 Mar; 14(3):203-9. PubMed ID: 27025367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL5 protein level: influence on breast cancer staging and lymph nodes commitment.
    Derossi DR; Amarante MK; Guembarovski RL; de Oliveira CEC; Suzuki KM; Watanabe MAE; de Syllos Cólus IM
    Mol Biol Rep; 2019 Dec; 46(6):6165-6170. PubMed ID: 31691056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DT-13, a saponin of dwarf lilyturf tuber, exhibits anti-cancer activity by down-regulating C-C chemokine receptor type 5 and vascular endothelial growth factor in MDA-MB-435 cells.
    Ren-Ping Z; Sen-Sen L; Yuan ST; Yu BY; Bai XS; Sun L; Zhang LY
    Chin J Nat Med; 2014 Jan; 12(1):24-9. PubMed ID: 24484593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential roles of the interaction between cancer cell-derived chemokine, CCL4, and intra-bone CCR5-expressing fibroblasts in breast cancer bone metastasis.
    Sasaki S; Baba T; Nishimura T; Hayakawa Y; Hashimoto S; Gotoh N; Mukaida N
    Cancer Lett; 2016 Aug; 378(1):23-32. PubMed ID: 27177471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer.
    Pervaiz A; Zepp M; Mahmood S; Ali DM; Berger MR; Adwan H
    Cell Oncol (Dordr); 2019 Feb; 42(1):93-106. PubMed ID: 30456574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.
    Gao D; Cazares LH; Fish EN
    BMC Cancer; 2017 Dec; 17(1):834. PubMed ID: 29216863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
    Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
    Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-inducible microRNA-224 promotes the cell growth, migration and invasion by directly targeting RASSF8 in gastric cancer.
    He C; Wang L; Zhang J; Xu H
    Mol Cancer; 2017 Feb; 16(1):35. PubMed ID: 28173803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
    Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
    Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.
    Nishikawa G; Kawada K; Nakagawa J; Toda K; Ogawa R; Inamoto S; Mizuno R; Itatani Y; Sakai Y
    Cell Death Dis; 2019 Mar; 10(4):264. PubMed ID: 30890699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells.
    Yamaguchi M; Takagi K; Narita K; Miki Y; Onodera Y; Miyashita M; Sasano H; Suzuki T
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
    Aldinucci D; Casagrande N
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1.
    Singh S; Bruder-Nascimento A; Belin de Chantemele EJ; Bruder-Nascimento T
    Biochem Pharmacol; 2022 Jan; 195():114859. PubMed ID: 34843718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
    Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
    FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cells promote triple-negative breast cancer cell metastasis
    Zhang W; Xu J; Fang H; Tang L; Chen W; Sun Q; Zhang Q; Yang F; Sun Z; Cao L; Wang Y; Guan X
    FASEB J; 2018 Jan; 32(1):276-288. PubMed ID: 28899878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR5-Mediated Signaling Is Involved in Invasion of Glioblastoma Cells in Its Microenvironment.
    Novak M; Koprivnikar Krajnc M; Hrastar B; Breznik B; Majc B; Mlinar M; Rotter A; Porčnik A; Mlakar J; Stare K; Pestell RG; Lah Turnšek T
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCL5 secreted by luminal B breast cancer cells induces polarization of M2 macrophages through activation of MEK/STAT3 signaling pathway via CCR5.
    Zhu YY; Zhao YC; Chen C; Xie M
    Gene; 2022 Feb; 812():146100. PubMed ID: 34864094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of the Regulation of Roundabout4 by Hypoxia-Inducible Factor-1α in Microvascular Endothelial Cells.
    Tian R; Liu Z; Zhang H; Fang X; Wang C; Qi S; Cheng Y; Su G
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2586-94. PubMed ID: 26066603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The saponin DT-13 inhibits gastric cancer cell migration through down-regulation of CCR5-CCL5 axis.
    Lin SS; Fan W; Sun L; Li FF; Zhao RP; Zhang LY; Yu BY; Yuan ST
    Chin J Nat Med; 2014 Nov; 12(11):833-40. PubMed ID: 25480514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis.
    Yang T; Chen M; Yang X; Zhang X; Zhang Z; Sun Y; Xu B; Hua J; He Z; Song Z
    Cancer Biol Ther; 2017 Oct; 18(10):806-815. PubMed ID: 28934010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.